Renaissance Technologies
TLSA icon

Renaissance Technologies’s Tiziana Life Sciences TLSA Stock Holding History

Renaissance Technologies’s Portfolio TLSA Stock Details TLSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-78,267
Closed -$75K – 4460
2021
Q4 		$75K Buy
+78,267
New +$104K ﹤0.01% 3732
2021
Q3 		– Sell
-65,340
Closed -$153K – 3841
2021
Q2 		$153K Buy
65,340
+17,193
+36% +$42.5K ﹤0.01% 3303
2021
Q1 		$133K Sell
48,147
-310,201
-87% -$1.03M ﹤0.01% 3199
2020
Q4 		$724K Buy
358,348
+133,700
+60% +$423K ﹤0.01% 2661
2020
Q3 		$748K Sell
224,648
-159,448
-42% -$621K ﹤0.01% 2653
2020
Q2 		$987K Buy
+384,096
New +$705K ﹤0.01% 2546

Other funds holding TLSA

HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AFP
Ausdal Financial Partners Davenport, Iowa $2.25B AUM 20.11% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Renaissance Technologies's TLSA Position: Q1 2022 in Review

Renaissance Technologies sold out of Tiziana Life Sciences (TLSA) in Q1 2022, closing a stake of 78,267 shares — an estimated $75K sold.

Renaissance Technologies first reported a position in TLSA in Q2 2020 and held it in 6 quarters. The position peaked at $987K in Q2 2020. 23 funds tracked by Wall St. Rank hold TLSA as of Q1 2022.

  • Renaissance Technologies reported no remaining Tiziana Life Sciences position as of Q1 2022 after selling out during the quarter.
  • Renaissance Technologies sold 78,267 Tiziana Life Sciences shares in Q1 2022, an estimated $75K.
  • Renaissance Technologies first reported a position in Tiziana Life Sciences in Q2 2020 and held it in 6 quarters.
  • Renaissance Technologies's Tiziana Life Sciences position peaked at $987K in Q2 2020.
  • 23 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q1 2022.

Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.